Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: A Study of the Effectiveness and Safety of SP2086 to Treat Type 2 Diabetes [Phase 2]
The Phase 2 trial evaluating SP2086 for Type 2 Diabetes has completed, reporting on its effectiveness and safety.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Efficacy and Safety of SP2086 as Monotherapy in Patients With Type 2 Diabetes [Phase 3]
Phase 3 update on efficacy and safety of SP2086 as monotherapy for Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: The Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity in Type 2 Diabetes
A completed clinical trial evaluating whether Roux-en-Y gastric bypass improves insulin sensitivity in people with type 2 diabetes mellitus …
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Efficacy and Safety Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes [Phase 2]
Phase 2 efficacy and safety study evaluating SP2086 in combination with metformin for type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment [Phase 4]
A Phase 4 trial compared sitagliptin to a dose increase of insulin in patients with type 2 diabetes on insulin therapy, and the study has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: The Effect of Maximum Body Weight in Lifetime on the Development of Type 2 Diabetes
A completed clinical trial evaluating whether maximum body weight over a lifetime influences the development of Type 2 diabetes, with condit…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Metabolic Effects of Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes [NA]
A completed clinical trial evaluated the metabolic effects of the probiotic Lactobacillus reuteri DSM 17938 in individuals with Type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]
A Phase III clinical trial is evaluating SP2086 in combination with metformin for Type 2 diabetes; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets) [Phase 1]
A Phase 1 food-effect bioavailability study of a fixed-dose combination of gemigliptin and metformin sustained-release (50/1000 mg total; 25…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 Diabetes [NA]
A completed clinical trial evaluating episodic, intensive blood glucose monitoring in adults with non-insulin-treated Type 2 diabetes and po…
-
FDA approval · 2013-10-18FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-Aventis U.S. LLC. This action approves changes to…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes [Phase 1]
This document reports the completion/update of a Phase I study evaluating polyethylene glycol loxenatide in patients with Type 2 diabetes.
-
CLINICAL_TRIALS research · 2013-10-18Clinical Trial Update: A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes [Phase 2]
A Phase 2 PK/PD study update for Polyethylene Glycol Loxenatide in patients with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes [NA]
This clinical trial investigated whether blocking angiotensin II receptors affects insulin resistance and adipose tissue cytokine profiles i…
-
FDA approval · 2013-10-17FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approves a supplemental application for JANUVIA (sitagliptin) filed by Merck, updating the product's label/indication.
-
FDA approval · 2013-10-17FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC. This action e…
-
FDA approval · 2013-10-17FDA Approved: KAZANO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for KAZANO (alogliptin and metformin hydrochloride) submitted by Takeda Pharmaceuticals America, Inc…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan [Phase 4]
A Phase 4 trial comparing vildagliptin to gliclazide as add-on therapy to metformin in Muslim patients with type 2 diabetes during Ramadan h…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment [Phase 3]
Phase 3 trial results evaluating linagliptin for safety and efficacy in adults with type 2 diabetes mellitus and moderate to severe renal im…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes [NA]
The GLYCOSA study evaluated whether PAP treatment improves glycemic control in adults with type 2 diabetes; the trial is completed and resul…
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study
A completed cross-sectional study assessed whether vildagliptin influences portal vein pressure in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients [NA]
This clinical trial update reports on the effects of metformin and pioglitazone on YKL-40 concentrations in adults with Type 2 Diabetes Mell…
-
FDA approval · 2013-10-15FDA Approved: GLUCOTROL XL — Supplemental Application (Roerig)
The FDA approved a supplemental application for Glucotrol XL (glipizide) submitted by Roerig.
-
FDA approval · 2013-10-15FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)
The FDA approved a supplemental application for glyburide from Teva Pharmaceuticals USA.
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients [Phase 2]
Phase 2 trial in Japanese patients with type 2 diabetes mellitus evaluated the efficacy and safety of dapagliflozin; results were posted aft…